SCHEMBL14201263

SCHEMBL14201263

CCCN(CCC)C(=O)CC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CA12 O43570 5/20 0.44
CA9 Q16790 4/20 0.44
CA2 P00918 3/20 0.44
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.40
APEX1 P27695 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TP53 P04637 1/20 0.38
CA1 P00915 4/20 0.37
SIGMAR1 Q99720 1/20 0.36
MLYCD O95822 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MAPT P10636 1/20 0.32
CA7 P43166 1/20 0.32
CA14 Q9ULX7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14945734 0.92 ALDH1A1 (0.42) HPGDALDH1A1CA12CA9CA2
SCHEMBL14201288 0.92 SIGMAR1 (0.46) HPGDALDH1A1CA12CA9CA2
SCHEMBL22797715 0.91 CA12 (0.41) HPGDALDH1A1CA12CA9CA2
SCHEMBL14201114 0.88 CA12 (0.41) HPGDALDH1A1CA12CA9CA2
SCHEMBL14201275 0.86 CA12 (0.48) HPGDALDH1A1CA12CA9CA2
SCHEMBL14200265 0.84 CA12 (0.39) HPGDALDH1A1CA12CA9CA2
SCHEMBL14200325 0.83 CA12 (0.45) HPGDALDH1A1CA12CA9CA2
SCHEMBL28545566 0.83 CA12 (0.44) CA12CA9CA2CA1
SCHEMBL22900144 0.82 ALDH1A1 (0.36) HPGDALDH1A1CA12CA9CA2
SCHEMBL14201067 0.81 CA12 (0.44) CA12CA9CA2CA1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3088397-B1 COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER CANBAS CO LTD (JP) 2019-04-10 EP disclosed
US-7365093-B2 Endothelin antagonists ABBOTT LABORATORIES (US) 2008-04-29 US disclosed
US-7208517-B1 Endothelin antagonists ABBOTT LABORTORIES (US) 2007-04-24 US disclosed